Tumors used in this study
| Tumor . | Strain . | Description . | Expression of CD25 . | Reference . |
|---|---|---|---|---|
| ASL1 | A | Spontaneous leukemia | + | (25) |
| AKSL2 | AKR | Spontaneous leukemia | − | (26) |
| RL♂1 | BALB/c | Radiation-induced leukemia | + | (27) |
| RL♀8 | BALB/c | Radiation-induced leukemia | − | (27) |
| EL4 | B6 | Dimethylbenzanthracene-induced leukemia | − | (28) |
| MOPC-70A | BALB/c | Mineral oil-induced myeloma | − | (29) |
| Meth A | BALB/c | Methylcholanthrene-induced fibrosarcoma | − | (30) |
| CMS17 | BALB/c | Methylcholanthrene-induced fibrosarcoma | − | (31) |
| Tumor . | Strain . | Description . | Expression of CD25 . | Reference . |
|---|---|---|---|---|
| ASL1 | A | Spontaneous leukemia | + | (25) |
| AKSL2 | AKR | Spontaneous leukemia | − | (26) |
| RL♂1 | BALB/c | Radiation-induced leukemia | + | (27) |
| RL♀8 | BALB/c | Radiation-induced leukemia | − | (27) |
| EL4 | B6 | Dimethylbenzanthracene-induced leukemia | − | (28) |
| MOPC-70A | BALB/c | Mineral oil-induced myeloma | − | (29) |
| Meth A | BALB/c | Methylcholanthrene-induced fibrosarcoma | − | (30) |
| CMS17 | BALB/c | Methylcholanthrene-induced fibrosarcoma | − | (31) |